ISPE is now accepting abstracts for oral/poster presentations in the area of pharmacoepidemiology and drug safety for our 2018 Mid-Year Meeting, which will be held at the Sheraton Centre Toronto Hotel, April 21-24, 2018.
Current full-time students that are lead author on the study are invited to submit abstracts for presentation at this meeting. Twelve student abstracts will be selected for oral presentations at the meeting in Toronto. Click here to Submit an Abstract or to read the FAQ.
The ISPE Nominations Committee is seeking nominees for election to the Society's Board of Directors for the positions of: President-Elect; Academic - Europe/Africa; Academic – Americas; Government - Asia/Pacific; Government – Americas; and Government - Europe/Africa. Nominees will be evaluated based on several criteria including their constituency and geography; demonstrated leadership in the field of pharmacoepidemiology; special contributions to the Society as well as their membership history.
Any member interested in a self-nomination should submit a 2-4 paragraph biography; a vision statement for the Society, and a digital photo to Kiyoshi Kubota, FISPE, Chair of the Nominating Committee, and Mark Epstein, Executive Secretary via email. Members can submit their suggestions of nominees to Professor Kubota and Dr. Epstein as well.
Consistent with the ISPE Policy Manual, the Nominations Committee will develop a list of candidates to stand for election in 2018. Please contact Mark Epstein if you have any questions about the nomination process.
Upcoming Webinar: Taking a Global View on Risk Minimization Programs
The BRACE SIG will be presenting the webinar "Taking a Global View on Risk Minimization Programs: Harmonizing Core vs. Regional Commitments. What is essential? What is adaptable?" on October 10, 1:00 PM (Eastern Time). This 2-part webinar will: 1) discuss scientific considerations in the local adaptation of risk minimization interventions using best practices from implementation science; and, 2) provide pragmatic recommendations for harmonization and successful implementation of risk minimization programs across differing geographic locales. Pharmaceutical risk minimization case examples will be presented to illustrate real-world challenges and solutions for global drug programs. Click here to register for the webinar using the Webinar ID: 697-309-651
2018 ICPE Call for Topics - Deadline October 12
ISPE is seeking ideas for potential plenary, keynote, and hot topics sessions for the 2018 ICPE, which will be held August 22-26, 2018 in Prague, The Czech Republic. The annual conference is developed organically from the interests of those within the Society with all ISPE members welcome to contribute. Members are invited to complete our online form by October 12th with suggestions for topics and speakers.
The Core Scientific Committee will look for suggestions that have broad applicability across the ISPE constituency; include perspectives that are historical, forward thinking, and/or offer applicable insights from other fields of study; and that encourage engaging and provocative discussion for the purpose of advancing the field. Potential topics will be reviewed by the 2018 ICPE Core Scientific Committee and considered for inclusion in the Prague program. The Committee will contact you if additional information is needed.
ISPOR/ISPE Summit on Real-World Evidence in Health Care Decision Making, October 20, 2017, Washington, DC
ISPOR and ISPE have collaborated on a joint task force to produce coordinated papers that make specific recommendations for improving the transparency and reproducibility of real-world evidence for use in health care decision making-especially those decisions at the regulatory and payer levels. This 1-day Summit will provide a forum for reviewing these task force reports, considering the perspectives of key stakeholders, and discussing future steps that could help enable these recommendations. click here for more information.